Jorge Vázquez López-Ibor

ORCID: 0000-0003-4483-9214
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrest and Resuscitation
  • Mechanical Circulatory Support Devices
  • Transplantation: Methods and Outcomes
  • Cardiac Structural Anomalies and Repair
  • Cardiovascular Function and Risk Factors
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cardiac Health and Mental Health
  • Cardiomyopathy and Myosin Studies
  • Cardiac Imaging and Diagnostics
  • Pulmonary Hypertension Research and Treatments
  • Eosinophilic Disorders and Syndromes
  • Potassium and Related Disorders
  • Frailty in Older Adults
  • Infective Endocarditis Diagnosis and Management
  • Multiple and Secondary Primary Cancers
  • Cardiac Valve Diseases and Treatments
  • Renal Transplantation Outcomes and Treatments
  • Oral and gingival health research
  • Breast Cancer Treatment Studies
  • Pericarditis and Cardiac Tamponade
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Sepsis Diagnosis and Treatment
  • Parathyroid Disorders and Treatments

Hospital Universitario de La Princesa
2024-2025

Centro de Investigación en Red en Enfermedades Cardiovasculares
2020-2025

Universidad Autónoma de Madrid
2025

Hospital Universitario Puerta de Hierro Majadahonda
2016-2024

Centro de Investigación Biomédica en Red
2020-2023

Hospital Clínico San Carlos
2007

<i>Background and Aim:</i> Since the appearance of transesophageal echocardiography, long-term prognosis patients with negative blood culture infective endocarditis (NBCIE) has been found to be similar that positive (PBCIE). Nevertheless, prognostic implications NBCIE in elderly (>65 years) not, date, well documented. Our aim was study compare it PBCIE. <i>Methods:</i> group composed 60 consecutive >65 years old a diagnosis IE (confirmed by vegetation analysis...

10.1159/000101691 article EN Gerontology 2007-01-01

Objectives To gather insights on the disease experience of patients with heart failure (HF) reduced ejection fraction (HFrEF), and assess how patients’ experiences narratives related to complement data collected through standardised patient-reported outcome measures (PROMs). Also, explore new ways evaluating burden experienced by caregivers. Design Observational, descriptive, multicentre, cross-sectional, mixed-methods study. Setting Secondary care, patient’s homes. Participants Twenty HFrEF...

10.1136/bmjopen-2021-053216 article EN cc-by-nc BMJ Open 2021-12-01

It is recommended to assess frailty prior heart transplantation (HT). Our objective was the prevalence of in patients listed for HT.The FELICITAR registry (Frailty Evaluation after List Inclusion, Characteristics and Influence on TrAnsplantation And Results) a prospective that includes HT three centers, from January 2017 April 2019. We assessed presence frailty, depression, cognitive impairment, quality life when included.Ninety-nine were included. Of this group, 30.6% frail, 55 (56.1%) had...

10.1111/ctr.14391 article EN Clinical Transplantation 2021-06-23

Combined pre-and post-capillary hypertension (CpcPH) is a relatively common complication of heart failure (HF) associated with poor prognosis. Currently, there no specific therapy approved for this entity. Recently, treatment beta-3 adrenergic receptor (β3AR) agonists was able to improve pulmonary hemodynamics and right ventricular (RV) performance in translational, large animal model chronic PH. The authors present the design phase II randomized clinical trial that tests benefits mirabegron...

10.1016/j.jacbts.2020.01.009 article EN cc-by-nc-nd JACC Basic to Translational Science 2020-03-11

Abstract The high cure rates of Hodgkin lymphoma (HL) make this oncological disease among those with the greatest number long‐term survivors. This single‐institution study including 383 HL patients up to 45 years follow‐up, analyses morbidity and mortality population after treatments in comparison overall Spanish population, investigates whether it has changed over time stratifying by periods time, as a consequence therapeutic optimization. median age was 34.8 (range 15–87) survival 30...

10.1002/hon.3131 article EN cc-by-nc-nd Hematological Oncology 2023-03-19

Cardiorenal programs have emerged to improve the management of cardiorenal disease (CRD). Evidence about benefits these is still scarce. This work aims evaluate performance a novel program and describe clinical profile outcomes patients with CRD.

10.1093/ckj/sfad169 article EN cc-by-nc Clinical Kidney Journal 2023-07-13

Albuminuria could potentially emerge as a novel marker of congestion in acute heart failure. However, the current evidence linking albuminuria and patients with congestive failure (CHF) remains somewhat scarce. This study aimed to evaluate prevalence cohort CHF, identify independent factors associated analyse correlation different parameters. is subanalysis Spanish Cardiorenal Registry, which we enrolled 864 outpatients value urinary albumin:creatinine ratio (UACR) at first visit. The median...

10.1093/ckj/sfae140 article EN cc-by Clinical Kidney Journal 2024-05-14

Abstract Introduction Paroxysmal atrial fibrillation (AF) is detected in approximately one-third of patients diagnosed with cryptogenic stroke undergoing prolonged ECG monitoring. Several risk factors for AF have been described, including left atrium (LA) enlargement, LA deformation, age, cardiovascular factors, and biomarkers as N-pro-BNP troponin. Specifically, enlargement a direct marker cardiopathy, which predisposes to AF. However, the methods calculate vary. While biplane volume...

10.1093/eurheartj/ehae666.087 article EN European Heart Journal 2024-10-01
Coming Soon ...